BioCentury
ARTICLE | Clinical News

Linaclotide: Phase III started

July 27, 2009 7:00 AM UTC

Ironwood and Forest began a double-blind, placebo-controlled, North American Phase III trial to evaluate 150 and 300 µg oral linaclotide once daily for 26 weeks in 750 patients. Ironwood and Forest ar...